Daily BriefsECM

Daily Brief ECM: Astera Labs IPO Valuation Analysis and more

In today’s briefing:

  • Astera Labs IPO Valuation Analysis
  • Migao Group IPO – Last Listing Didn’t Do Well, This One Might Struggle Too


Astera Labs IPO Valuation Analysis

By Douglas Kim

  • Our base case valuation is market cap of US$5.4 billion or target price of US$35.9 per share, which is 20% higher than high end of the IPO price range (US$30).
  • We estimate Astera Labs (ALAB US) to generate revenue of $221.3 million (up 91.1% YoY) in 2024 and $304.5 million (up 37.5% YoY) in 2025.
  • Many investors are willing to take extra risk to invest in companies such as Astera Labs that could generate strong sales growth amid rush to aggressively expand AI capabilities.

Migao Group IPO – Last Listing Didn’t Do Well, This One Might Struggle Too

By Clarence Chu

  • Migao Group Holdings (9879 HK) is looking to raise up to US$124m in its Hong Kong IPO.
  • Migao Group (Migao) is a vertically-integrated national potash fertilizer company in China.
  • In this note, we look at the firm’s past performance and share our thoughts on valuation.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars